Related Experiment Videos

[Oral anticoagulation in elderly people]

S Rochat1, C Büla

  • 1Service de gériatrie et readaptation gériatrique Département de médecine CHUV, 101 I Lausanne. stephane.rochat@chuv.ch

Revue Medicale Suisse
|December 6, 2005
PubMed

Insights

Anticoagulant therapy for elderly atrial fibrillation patients involves balancing stroke prevention against bleeding risks. Guidelines recommend treatment for those over 75, and consider it for those 65-75 with risk factors.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Pharmacology

Context:

  • Oral anticoagulation in elderly patients with atrial fibrillation presents unique challenges.
  • Treatment decisions necessitate a careful balance between preventing ischemic stroke and managing major hemorrhage risks, including intracranial bleeding.

Purpose:

  • To outline the complexities of initiating oral anticoagulation in elderly patients diagnosed with atrial fibrillation.
  • To emphasize the importance of integrating patient preferences into the shared decision-making process for anticoagulant therapy.

Summary:

  • Current guidelines advocate for anticoagulation in atrial fibrillation patients aged 75 and older, provided no contraindications exist.
  • Anticoagulation is also recommended for patients aged 65 to 75, particularly those with cardiovascular risk factors.
  • Individual patient characteristics and preferences are crucial for informed treatment decisions.

Impact:

  • Optimizing anticoagulant therapy in the elderly can reduce stroke incidence while minimizing bleeding complications.
  • This approach supports personalized medicine and adherence to treatment guidelines in geriatric cardiology.
  • Facilitates informed patient-doctor discussions regarding the benefits and risks of anticoagulation.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...